Article Text

PDF
▼Dronedarone for atrial fibrillation?
  • Relevant BNF section: BNF 2.3.2

Abstract

Atrial fibrillation (AF) is the commonest sustained heart arrhythmia and is associated with significant morbidity and mortality, with, for example, one in five of all strokes being attributable to the condition.1 ▼Dronedarone (pronounced dro-ne-da-roan) (Multaq – sanofi-aventis) is a new anti-arrhythmic drug related to the established anti-arrhythmic amiodarone. It is licensed for use in clinically stable adult patients with a history of, or current, non-permanent AF to prevent recurrence of AF or to lower ventricular rate. Here we review its role in the management of patients with non-permanent AF.

Statistics from Altmetric.com

  • Relevant BNF section: BNF 2.3.2

View Full Text

Footnotes

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.